{
  "LinkTitle": "D-2022-1368",
  "Status": "Initial",
  "InitialDMPReviewStatus": "Reviewed",
  "Funder": "BOF",
  "ProjectTitle": "Kidney stem/progenitor cells as a potent source for kidney-targeted cell therapy",
  "InitialFeedbackHistory": "23/06/2022\r\nPlease note you used the general KU Leuven template, please select the Internal Funds template in DMPonline for your future BOF funded projects\n1. Personal data: Pseudonymized data is still personal data according to the GDPR, please register this via the GDPR questionnaire: www.uzleuven.be/nl/clinical-trial-center/ctc-gdpr-questionnaire \n3. Ethics: Human bodily material now falls under the scope of the 2018 biobank law, please contact the UZL ethics committee for approval to work with human kidneys, for more information see www.uzleuven.be/en/uz-kuleuven-biobank\n7. Open access publication is not part of a DMP, please describe here how you will share data underlying your publications here, which repositories are you considering? Under metadata you mention GEO, the European EGA or other EBI repositories may be a better alternative if this is human data : https://ega-archive.org/; https://www.ebi.ac.uk/submission/. In addition you an now also use  KU Leuven RDR (www.kuleuven.be/rdm/en/rdr)  \nPlease update the sections on ethics and personal data and submit your updated DMP as intermediate",
  "label": "good with suggestions"
}